Concomitant use of VAQTA® with PedvaxHIB® and Infanrix® in 12 to 17 month old children-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concomitant use of VAQTA® with PedvaxHIB® and Infanrix® in 12 to 17 month old children

Published:2015-08-26 Issue:2 Volume:12 Page:503-511
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Petrecz Maria,Ramsey Keith P,Stek Jon E,Martin Jason C,Klopfer Stephanie O,Kuter Barbara,Schödel Florian P,Lee Andrew W

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/21645515.2015.1080395

Reference4 articles.

1. Safety, Tolerability and Immunogenicity of VAQTA Given Concomitantly versus Nonconcomitantly With Other Pediatric Vaccines in Healthy 12-Month-Old Children

2. Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine Administered Concomitantly With Diphtheria-Tetanus-Acellular Pertussis and Haemophilus influenzae Type B Vaccines to Children Less Than 2 Years of Age

3. Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine When Coadministered With Diphtheria-tetanus-acellular Pertussis and Haemophilus influenzae Type B Vaccines in Children 15 Months of Age

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conventional vaccination methods: Inactivated and live attenuated vaccines;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

2. A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country;Vaccine;2023-02

3. Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis;Vaccine;2021-06

4. Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccines;Human Vaccines & Immunotherapeutics;2018-11-15

5. Vaccines;Side Effects of Drugs Annual;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3